Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 23, Number 5—May 2017

Research

Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April–August 2016

Michelle S. ChevalierComments to Author , Brad J. Biggerstaff, Sridhar V. Basavaraju, M. Cheryl Bañez Ocfemia, Jose O. Alsina, Consuelo Climent-Peris, Robin R. Moseley, Koo-Whang Chung, Brenda Rivera-García, Melissa Bello-Pagán, Lisa L. Pate, Susan A. Galel, Phillip Williamson, and Matthew J. Kuehnert
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M.S. Chevalier, S.V. Basavaraju, M.C. Bañez Ocfemia, R.R. Moseley, K.-W. Chung, M.J. Kuehnert); Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (B.J. Biggerstaff); Banco de Sangre de Servicios Mutuos, San Juan, Puerto Rico (J.O. Alsina); Banco de Sangre del Centro Medico of the Administración de Servicios Médicos, San Juan (C. Climent-Peris); Puerto Rico Department of Health, San Juan (B. Rivera-García, M. Bello-Pagán); Roche Molecular Systems, Inc., Pleasanton, California, USA (L.L. Pate, S.A. Galel); Creative Testing Solutions, Tempe, Arizona, USA (P. Williamson)

Main Article

Table 1

Characteristics of blood donors screened for Zika virus infection with cobas Zika ID-NAT at BSIS and ASEM, Puerto Rico, April 3–August 12, 2016*

Characteristic Total donors screened, no. (%) Presumptive viremic donors, no. (%)
Total
 21,468 (100)
 190 (100)
Sex
M 14,407 (67.1) 142 (74.7)
F
 7,061 (32.9)
 48 (25.3)
Age at donation, y
16–29 4,313 (20.1) 39 (20.5)
30–44 7,179 (33.4) 51 (26.8)
45–59 7,046 (32.8) 67 (35.3)
60–74 2,751 (12.8) 31 (16.3)
>75
 179 (0.8)
 2 (1.1)
Month of donation
April 4,339 (20.2) 14 (7.4)
May 4,891 (22.8) 33 (17.4)
June 5,602 (26.1) 67 (35.3)
July 4,773 (22.2) 56 (29.5)
August
 1,863 (8.7)
 20 (10.5)
Region of residence
Aguadilla 751 (3.5) 9 (4.7)
Arecibo 1,883 (8.8) 15 (7.9)
Bayamón 4,797 (22.3) 45 (23.7)
Caguas 4,359 (20.3) 19 (10.0)
Fajardo 979 (4.6) 2 (1.1)
Mayagüez 917 (4.3) 2 (1.1)
Metro/San Juan 6,081 (28.3) 84 (44.2)
Ponce
 1,701 (7.9)
 14 (7.4)
Donation type
First-time 20,912 (97.4) 168 (88.4)
Repeat 556 (2.6) 22 (11.6)

*Data for August 1–August 12, 2016 available only for BSIS. cobas Zika, Roche Molecular Systems, Inc., Pleasanton, CA, USA. ASEM, Banco de Sangre del Centro Médico de la Administración de Servicios Médicos; BSIS, Banco de Sangre de Servicios Mutuos; ID-NAT, individual nucleic acid testing.

Main Article

Page created: April 17, 2017
Page updated: April 17, 2017
Page reviewed: April 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external